These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29276815)

  • 1. The Anticancer Potential of Peroxisome Proliferator-Activated Receptor Antagonists.
    De Lellis L; Cimini A; Veschi S; Benedetti E; Amoroso R; Cama A; Ammazzalorso A
    ChemMedChem; 2018 Feb; 13(3):209-219. PubMed ID: 29276815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of novel benzothiazole amides: Evaluation of PPAR activity and anti-proliferative effects in paraganglioma, pancreatic and colorectal cancer cell lines.
    Ammazzalorso A; De Lellis L; Florio R; Laghezza A; De Filippis B; Fantacuzzi M; Giampietro L; Maccallini C; Tortorella P; Veschi S; Loiodice F; Cama A; Amoroso R
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2302-2306. PubMed ID: 31272790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking the peroxisome proliferator-activated receptor (PPAR): an overview.
    Ammazzalorso A; De Filippis B; Giampietro L; Amoroso R
    ChemMedChem; 2013 Oct; 8(10):1609-16. PubMed ID: 23939910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer properties of 4-thiazolidinone derivatives depend on peroxisome proliferator-activated receptor gamma (PPARγ).
    Szychowski KA; Leja ML; Kaminskyy DV; Kryshchyshyn AP; Binduga UE; Pinyazhko OR; Lesyk RB; Tobiasz J; Gmiński J
    Eur J Med Chem; 2017 Dec; 141():162-168. PubMed ID: 29031063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Peroxisome proliferator-activated receptors (PPAR). Antiproliferative properties].
    Hojka A; Rapak A
    Postepy Hig Med Dosw (Online); 2011 Jun; 65():404-13. PubMed ID: 21734325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer.
    Sertznig P; Seifert M; Tilgen W; Reichrath J
    J Cell Physiol; 2007 Jul; 212(1):1-12. PubMed ID: 17443682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines.
    Burton JD; Castillo ME; Goldenberg DM; Blumenthal RD
    Anticancer Drugs; 2007 Jun; 18(5):525-34. PubMed ID: 17414621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic effect of a family of peroxisome proliferator-activated receptor antagonists in colorectal and pancreatic cancer cell lines.
    Ammazzalorso A; De Lellis L; Florio R; Bruno I; De Filippis B; Fantacuzzi M; Giampietro L; Maccallini C; Perconti S; Verginelli F; Cama A; Amoroso R
    Chem Biol Drug Des; 2017 Nov; 90(5):1029-1035. PubMed ID: 28544586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptors and their relevance to dermatology.
    Friedmann PS; Cooper HL; Healy E
    Acta Derm Venereol; 2005; 85(3):194-202. PubMed ID: 16040401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome Proliferator-Activated Receptors and their Ligands in Cancer Drug- Resistance: Opportunity or Challenge.
    Yousefi B; Zarghami N; Samadi N; Majidinia M
    Anticancer Agents Med Chem; 2016; 16(12):1541-1548. PubMed ID: 26845135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, in vitro evaluation, and molecular modeling investigation of benzenesulfonimide peroxisome proliferator-activated receptors α antagonists.
    Ammazzalorso A; Carrieri A; Verginelli F; Bruno I; Carbonara G; D'Angelo A; De Filippis B; Fantacuzzi M; Florio R; Fracchiolla G; Giampietro L; Giancristofaro A; Maccallini C; Cama A; Amoroso R
    Eur J Med Chem; 2016 May; 114():191-200. PubMed ID: 26974385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pleiotropic peroxisome proliferator activated receptors: Regulation and therapeutics.
    Dixit G; Prabhu A
    Exp Mol Pathol; 2022 Feb; 124():104723. PubMed ID: 34822814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting components of the stress system as potential therapies for the metabolic syndrome: the peroxisome-proliferator-activated receptors.
    Yumuk VD
    Ann N Y Acad Sci; 2006 Nov; 1083():306-18. PubMed ID: 17148746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of PPAR receptor in different diseases and their ligands: Physiological importance and clinical implications.
    Mirza AZ; Althagafi II; Shamshad H
    Eur J Med Chem; 2019 Mar; 166():502-513. PubMed ID: 30739829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor-gamma ligands as cell-cycle modulators.
    Theocharis S; Margeli A; Vielh P; Kouraklis G
    Cancer Treat Rev; 2004 Oct; 30(6):545-54. PubMed ID: 15325034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual screening and biological evaluation of PPARγ antagonists as potential anti-prostate cancer agents.
    Almahmoud S; Elix CC; Jones JO; Hopkins CR; Vennerstrom JL; Zhong HA
    Bioorg Med Chem; 2021 Sep; 46():116368. PubMed ID: 34433102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics?
    Han S; Roman J
    Anticancer Drugs; 2007 Mar; 18(3):237-44. PubMed ID: 17264754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, characterization and biological evaluation of ureidofibrate-like derivatives endowed with peroxisome proliferator-activated receptor activity.
    Porcelli L; Gilardi F; Laghezza A; Piemontese L; Mitro N; Azzariti A; Altieri F; Cervoni L; Fracchiolla G; Giudici M; Guerrini U; Lavecchia A; Montanari R; Di Giovanni C; Paradiso A; Pochetti G; Simone GM; Tortorella P; Crestani M; Loiodice F
    J Med Chem; 2012 Jan; 55(1):37-54. PubMed ID: 22081932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
    Sertznig P; Seifert M; Tilgen W; Reichrath J
    Am J Clin Dermatol; 2008; 9(1):15-31. PubMed ID: 18092840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptors: role of isoform gamma in the antineoplastic effect of iodine in mammary cancer.
    Nunez-Anita RE; Cajero-Juarez M; Aceves C
    Curr Cancer Drug Targets; 2011 Sep; 11(7):775-86. PubMed ID: 21762085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.